Vectorite Biomedical

Vectorite Biomedical Rule of 40

The Rule of 40 of Vectorite Biomedical (4170.TWO) as of Oct 10, 2026 is -29.38 %. In the previous year, Rule of 40 was -41.53 % — a change of -29.24% (higher).

Rule of 40

-29.38 %

YoY

-29.24%

Last updated:

Rule of 40 of Vectorite Biomedical is 2025 -29.38 % . Rule of 40 of Vectorite Biomedical was 2024 -41.53 % . It decreases by -29.24% higher compared to the previous year.

The Vectorite Biomedical Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
9.89 TWD
Jan 1, 2019
-462.33 TWD
Jan 1, 2020
-255.76 TWD
Jan 1, 2021
-130.12 TWD
Jan 1, 2022
120.32 TWD
Jan 1, 2023
1.27 TWD
Jan 1, 2024
-41.53 TWD
Jan 1, 2025
-29.38 TWD
The Vectorite Biomedical Rule of 40 history
YEARRule of 40YoY
-29.38 %-29.24%
-41.53 %-3,367.09%
1.27 %-98.94%
120.32 %-192.47%
-130.12 %-49.12%
-255.76 %-44.68%
-462.33 %-4,772.66%
9.89 %-96.42%
276.01 %-252.95%
-180.45 %-43.59%
-319.90 %—
Access this data via the Eulerpool API
Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

Rule of 40 of Vectorite Biomedical is -29.38 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API
Get Free API Key

Quality — Vectorite Biomedical

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — Vectorite Biomedical